Leading the
global fight
against cancer
 

Union for International Cancer ControlUICC

"The Union for International Cancer Control (UICC) unites and supports the cancer community to reduce the global cancer burden, to promote greater equity, and to ensure that cancer control continues to be a priority in the world health and development agenda."

 
Our main missions
icon_convening-orange.png
Convening

Convening the global cancer control community through our keystone events

icon_capacity-building-orange_0.png
Capacity Building

Developing capacity building initiatives to strengthen the cancer community

icon_advocacy-orange.png
Advocacy

Promoting cancer in the global health and development agendas

Our key platforms
icon_wcd-blue.png
World Cancer Day 2021 – 4 Feb – I Am And I Will

137

days

World Cancer Leaders' Summit icon
2021 World Cancer Leaders' Summit

400

days

Latest news and updates
Our news and updates
Tsetsegsaikhan Batmunkh, CEO of the Country Champion organisation National Cancer Council Mongolia, at World Cancer Leaders' Summit 2019
16 September 2020

Become a Country Champion of UICC’s Cancer Advocates programme

UICC is launching a call for expressions of interest for member organisations from low- and middle-income countries to join its Cancer Advocates programme and inspire national action on cancer control in their countries.

Lorna Warwick, CEO of Lymphoma Coalition
14 September 2020

World Lymphoma Awareness Day – Focusing on patients and their gratitude

For World Lymphoma Awareness Day on 15th September, Lorna Warwick, CEO of the Lymphoma Coalition, speaks about “a world of thanks” and the particular challenges of lymphoma patients and caregivers.

Cancer care at Acibadem Kozyatağı Hospital
7 September 2020

Accountability on NCDs: The missing link between commitment and action

NCDs are finally receiving the attention they require as the leading cause of death globally, particularly due to the link with COVID-19, but now governments must be held accountable to translate commitment into action and results.

pexels-máximo-2914265.jpg
3 September 2020

The final year of World Cancer Day’s ‘I Am and I Will’ campaign kicks off this month

Join supporters around the world on Facebook Live this 22nd September for the official launch 

Spotlight on
WHO adopts the Global Strategy towards the elimination of cervical cancer
11 August 2020

A historic milestone in the global movement to eliminate cervical cancer

WHO’s Global Strategy for the elimination of cervical cancer marks an unprecedented move to mobilise the international health community and ensure that future generations of women do not die from a preventable cancer.

Cancer and coronavirus resources
25 March 2020

Cancer and coronavirus resources

As health systems in many countries become overwhelmed by the coronavirus, UICC is keenly aware of the immense challenges this situation creates for cancer patients and caregivers. Find our list of resources on cancer and coronavirus here (regular updates).

From our network
News feed
14 September 2020

New studies presented at the ESMO 2020 Virtual Congress show that safety measures adopted to minimize the risk of exposure to Covid-19) have generated a long delay in cancer care and research and that medical professionals face burnout.

Source: Info Salus
9 September 2020

This article takes stock of advances and unmet needs in the oncology pharmaceutical market. What will it take to deliver innovation to patients over the next ten years?

Source: McKinsey
8 September 2020

Mr Hunt said Australia was successful in adding Cervical Cancer Prevention and Control to the World Health Assembly agenda in 2018 and led the development of the resolution to eliminate cervical cancer.

Source: Health Dispatch
7 September 2020

The use of water pipes and passive exposure to their smoke are as harmful as conventional tobacco.

4 September 2020

The NCD Countdown to 2030 tracks global progress on non-communicable diseases against commitments to reduce deaths from NCDs by a third by 2030. 

Source: The Lancet
Member spotlight
Cancer Cafe
Cancer Cafe

The Cancer Cafe is a non-profit organisation that tailor-makes solutions for people living with cancer by providing simplified, holistic, credible, and consistent information about cancer management.

The organisation brings healthcare providers and resources out of the hospitals and into the communities where cancer patients are better able to articulate their unique needs, and community and family members are also included in learning about and providing support for cancer prevention and care to those affected.

Cancer Cafe’s guiding principles are:

  1. Creating local solutions to local problems with a global-mindset outlook;
  2. Adapting innovative culturally accepted solutions that encourage sustainability;
  3. Service to society with a clear sense of the organisations’ interconnectedness.

During the COVID-19 pandemic, Cancer Cafe have been relying on partnerships and technology to assist patients with maintaining access to their needed healthcare services, as well as with proper nutrition through the provision of fortified meals.

Our Partners
ASCP_Spelled Out_Flat_2C.jpg
American Society for Clinical Pathology (ASCP)

The American Society for Clinical Pathology (ASCP) is the world’s largest professional membership organisation for pathologists and laboratory professionals. In addition to their educational and certification missions around the world, they maintain a very active global health delivery program focused on laboratory strengthening in all aspects. Through their 10 year + work with PEPFAR, they have improved HIV-related testing and access in ~20 countries, trained more than 3000 individuals, and continue to deliver innovated diagnostics their partners. The Cancer Diagnostics and Treatment in Africa Initiative, created and led by ASCP, aims for 100% access to diagnostics for patients with cancer through on-site assessment, implementation planning, and, ultimately, connectivity to experts around the world through telepathology. With more than 100,000 members, the society’s influence has guided the application and evolution of the pathology and laboratory medicine specialty since 1922. ASCP is leading the way in global health pathology.

Amgen logo
Amgen

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

Astellas
Astellas

The Astellas Group aims to become a R&D-driven global pharmaceutical company contributing to people’s health. Astellas’s business philosophy has three elements — raison d'être, mission and beliefs. This business philosophy expresses the company’s aim to contribute to the health of people around the world through the provision of highly effective and trustworthy pharmaceuticals, while continuously increasing the Company's enterprise value.

Bristol-Myers Squibb Logo
Bristol-Myers Squibb (BMS)

Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines to patients with serious diseases.

Cancerfonden logo
Cancerfonden

Founded in 1951 to support cancer research, the Swedish Cancer Society is an independent non-profit organization with the vision of finding cures for cancer. The overall aim of the Society is to achieve a higher survival rate and a reduction in the incidence of cancer. Their main task is to raise and distribute money for cancer research. As one of the largest financiers of cancer research in Sweden, the Swedish Cancer Society essentially acts as a national research council. Thanks to the organization’s extensive knowledge about cancer, the Swedish Cancer Society is also active in areas such as public opinion and spreading knowledge about cancer, as well as results of cancer research.

CACA logo.jpg
China Anti-Cancer Association (CACA)

Established in 1984, the China Anti-Cancer Association (CACA) is a non-government and non-profit organisation with a mission to unite people involved in all branches of oncology with a shared interest in fighting cancer. CACA is dedicated to improving cancer control in China through increasing the survival rates, and decreasing the incidence and mortality rates of cancer. CACA plays an important role in promoting academic exchange, organising public education, establishing collaboration with international cancer societies, and providing data and advice to the Chinese government for making strategies and policies on cancer control. The branches consist of 45 professional societies, 47 full membership organisations, and 30 local anti-cancer associations with a total membership exceeding 47,000.

CUBEBIO_logo.png
CUBEBIO

CUBEBIO is a biomedical company, headquartered in Seoul, South Korea, dedicated to researching and developing cancer diagnostic biomarkers and in vitro diagnostics. The company also possesses more than 30 patents in relation to cancer diagnosis. Since its establishment, CUBEBIO commits itself to the continuous research and development for global health improvements by detecting cancer early through self-diagnosis by means of urine as a specimen. CUBEBIO’s urine-based self-diagnostic technology enables anyone to check their cancer status fast, accurately, economically, and frequently, thereby making early screening possible and, in the case of cancer patients, allowing them to monitor their cancer for progression or recurrence.

CUBEBIO aims to enter world markets by fostering close working relations with cancer societies, foundations, and research centers in each and every country. By doing so, CUBEBIO works towards creating a new culture where complex cancer diagnostic procedure becomes simpler and more accessible by self-diagnosis, regardless of time and place, and thus emerges as a new global leader in the healthcare industry.

DKG
DKG Krebsgesellschaft

The German Cancer Society (DKG) is the largest scientific and specialist oncology company in Germany with headquarters in Berlin. They are engaged in cancer care on the basis of evidence-based medicine, interdisciplinary and consequent quality standards. In total, DKG has about 7600 members, organised in 24 working groups, 16 regional cancer societies and 34 sponsors from research-based pharmaceutical industries, scientific publishers and health insurances. Since cancers need to be cross-treated and researched, their members are not only medical doctors of all sections, but also basic researchers, medical technical assistants, nurses, psychologists and other professionals who work on cancer.

DKG specialises in certification of oncological care institutions, development of clinical practice guidelines, coordination of guidelines in the framework of the German Guideline Program of Oncology (GGPO), development and transfer of oncological knowledge, and improvement of information given to patients.

Fondation Philantropia
Fondation Philantropia

An umbrella foundation associated with the bank Lombard Odier and a registered charity, Fondation Philanthropia has been helping its donors bring their philanthropic initiatives to fruition in all areas of social responsibility since 2008. It provides philanthropic expertise and support to those who wish to develop a philanthropic project in line with their background, desires and ambitions. The Foundation offers its donors a legal, financial and philanthropic framework for made-to-measure projects.

The Foundation now operates more than 20 personal funds and has received over 115 million Swiss francs in donations, of which over a third has already been distributed or committed. Its donors have been highly committed to the fight against cancer, with over 15 million spent on the cause.

Friends of Cancer Patients (FOCP)
Friends of Cancer Patients (FOCP)

Friends of Cancer Patients UAE (FoCP UAE) charity is a non-profit organisation, founded in September 1999 under the directives and patronage of Her Highness Sheikha Jawaher Bint Mohammed Al Qasimi, Wife of the Ruler of Sharjah, United Arab Emirates (UAE).

FoCP UAE provides a broad spectrum of support for its patients including financial support, which entails covering treatment expenses for chemotherapy, radiation and other needed medications, in addition to expenses for investigative and surgical procedures including bone marrow transplants and prosthetic limbs. FoCP UAE provides transportation and food allowance for underprivileged cancer patients and facilitates sending patients abroad for specialised treatment. FoCP UAE also provides moral support, offering cancer patients and their families psychological consultations and Hajj and Umrah services.

ICONGROUP__CMYK_Logo.png
ICON Group

Icon Group is a leading provider of cancer care across Australasia. Icon believes in bringing the best cancer treatment possible, to as many people as possible, as close to home as possible. They do this through leveraging the latest technology, collaborating with like-minded partners and investing in outstanding people.

Institut National du Cancer
Institut National du Cancer

The French National Cancer Institute (INCa) is the preeminent health and science agency in charge of cancer control in France, created under the Public Health Act of 9th August 2004. It reports to the ministries for Health and for Research.

The Institute is a public interest grouping (GIP) which brings together State representatives, charities, health insurance funds, research organisations and hospital federations. These stakeholders share a common goal of reducing the incidence of avoidable cancers and the number of cancer deaths, improving the quality of life of people with cancer during and after their illness, and reducing inequalities related to cancer.

The Institute provides an integrated approach encompassing all cancer-control dimensions (health, scientific, social and economic) and areas of intervention (prevention, screening, care and research) for the benefit of patients and their relatives.

To catalyse progress, the INCa acts as an interface with patients, their friends and families, the healthcare system users, general public, healthcare professionals, researchers, experts and decision-makers.

Capacity Building
MERCK_LOGO_Blue_RGB.png
Merck KGaA

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2016, Merck generated sales of € 15.0 billion in 66 countries.  Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the “Merck” name and brand except in the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

MSD be well
MSD (Merck & Co)

For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bring forward medicines and vaccines for the world’s most challenging diseases.  MSD is a trade name of Merck & Co., Inc., Kenilworth, N.J., USA. Through their prescription medicines, vaccines, biologic therapies, and animal health products, they work with customers and operate in more than 140 countries to deliver innovative health solutions. MSD also demonstrates their commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola.

National Cancer Institute (NCI)
National Cancer Institute (NCI)

The National Cancer Institute (NCI) is the federal government's principal agency for cancer research and training. The NCI coordinates the National Cancer Program, which conducts and supports research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients.

Novartis logo
Novartis Oncology

Novartis Oncology is a global leader in transforming outcomes for people with cancer. We offer a wide range of innovative therapies to help meet patient needs and have one of the strongest, most productive pipelines in the industry. Our research is driven by a distinctive scientific and clinical strategy focused on precision oncology – understanding how cancer develops on a genomic level and developing drugs that hone in on those targets.

Oman Cancer Association
Oman Cancer Association

The Oman Cancer Association (OCA) is a non-governmental, non-for-profit umbrella organization. The inception of the Association was in the 2000 but was registered at the Ministry of Social Development in 2004. OCA is the brainchild of a 4 times cancer survivor Ms. Yuthar AlRawahi who started the initiatives in 1999.

The Oman Cancer Association is 17 years old and serves the community to achieve its vision, Mission and Objectives. This is done through special projects, landmark projects, fund raising and creating awareness towards all cancers. Concentrating on awareness, empowerment, human resource development and research. We collaborate and support other similar organization within the region and globally.

Pfizer
Pfizer

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development and manufacture of healthcare products. Our global portfolio includes medicines and vaccines, as well as many of the world’s best-known consumer healthcare products. We work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. We collaborate with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world.

Roche logo
Roche

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.

Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims for improving patient access to medical innovations by working with all relevant stakeholders. Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines.

The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2016 employed more than 94,000 people worldwide.

OManroyalhospital.jpg
Royal Hospital - Ministry of Health (Oman)

The Royal Hospital is owned and administered by the Ministry of Health, Sultanate of Oman. Commissioned in 1987, it is an important landmark in the development of health services in the Sultanate during the renaissance program of the Government of His Majesty Sultan Qaboos bin Said in this prosperous period of Oman’s contemporary history. Through this Hospital, the Government aims at providing specialist and super-specialist care of the highest standard.

https://www.moh.gov.om/en/web/royal-hospital

Sanofi
Sanofi

Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare. More than 110,000 people at Sanofi are dedicated to make a difference on patients’ daily life, wherever they live and enable them to enjoy a healthier life.

UICC Japan
UICC Japan

The Japan National Committee for UICC is a group of Japanese organisations that are members of the Union for International Cancer Control (UICC), gathered to support the UICC to strive to realise the World Cancer Declaration. Currently UICC-Japan is composed of 29 full Japanese UICC members, including major cancer specialists in Japan, cancer centres, research institutes, research funds, hospitals and cancer associations.

Give us
your support
 

Are you organising a cancer-related event and would like to feature it in our events section?

 

Are you interested in joining a dynamic network of over 1,000 members?

 

Would you like to support the work of UICC and its member organisations?